Alpha Teknova (TKNO)

• Market cap: $308M
• 1 day: 3.42%
• 5 days: 15.05%
• 1 month: 4.40%
• 3 months: -17.29%
• 6 months: 0.00%
• Year to date: -20.07%
• 1 year: 288.89%
• 5 years: -73.40%
• 10 years: -73.40%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Employees: 173

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

114% more capital invested

Capital invested by funds: $24.9M [Q3] → $53.2M (+$28.4M) [Q4]

47% more funds holding

Funds holding: 32 [Q3] → 47 (+15) [Q4]

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

2.31% more ownership

Funds ownership: 9.64% [Q3] → 11.95% (+2.31%) [Q4]